Artificial Cells Nanomedicine and Biotechnology · 2019 · 29 citations · 25 references
MedicineCancer BiologyOncologyGene ExpressionMolecular OncologyTumor ProgressionCancer BiomarkersCancer NanomedicineCancer ProgressionMalignant NeoplasmsMicrorna BiologyNanomedicineCancer NanotherapyHepatocellular Carcinoma PathogenesisMicrorna Function In CancerMicrorna In CancerMicrorna ModulationMicrorna Regulation In CancerMicrorna TherapeuticsPrognostic Biomarker Discovery
Abnormal expression of microRNAs (miRNAs) contributes to tumour growth and invasion. MiR-326 expression often down-regulates in several kinds of cancer and low expression of miR-326 is linked with poor prognosis in cancer patients. In the present study, we aimed to explore the modulatory mechanism of miR-326 in hepatocellular carcinoma (HCC). miR-326 expression was significantly decreased in HCC cell lines and tissues. miR-326 decreased HCC cell growth by affecting cell-cycle progression and by promoting apoptosis. In addition, miR-326 inhibited HCC cell invasion by decreasing the EMT phenotype. We found that miR-326 functioned as a tumour suppressor by repressing its down-stream target PDK1. C-myc contributed to miR-326 down-regulation through binding at its promoter and inhibited its expression. Based on these results, we conducted a therapeutic experiment by using gold nano-particles (AuNPs) carrying miR-326. Restoration of miR-326 reduced tumour growth in vivo. Our findings suggest that miR-326 may be a candidate prognostic biomarker and a target for new therapies in HCC patients.
25
Ji‐hang Yuan, Fu Yang, Fang Wang et al. · Cancer Cell · 2014 · 1.6K citations · Full text
Layer-by-Layer Assembled Gold Nanoparticles for siRNA Delivery
Asmaa M. Elbakry, Alaa A. Zaky, Renate Liebl et al. · Nano Letters · 2009 · 422 citations
A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis
Mengxuan Lu, Xia Kong, Huai-Gao Wang et al. · Oncotarget · 2017 · 109 citations · Full text